Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 7615227
Use of CpG oligodeoxynucleotides to induce angiogenesis
granted -
US 7612093
Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy
granted -
US 7612188
Modified vitamin K. dependent polypeptides
granted -
US 7612203
Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
granted -
US 7612107
Treatment and inhibition of disease conditions using flexible heteroarotinoids
granted -
US 7611533
Coated implantable medical device
granted -
US 7612073
Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
granted -
US 7612064
Sulfopyrroles
granted -
US 7612065
Inhibitors of c-JUN N-terminal kinases (JNK)
granted -
US 7612037
Cross-linked glycopeptide-cephalosporin antibiotics
granted -
US 7611885
Pharmaceutically compatible method for purifying intact bacterial minicells
granted -
US 7611704
Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
granted -
US 7611722
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
granted -
US 7611728
Osmotic delivery of therapeutic compounds by solubility enhancement
granted -
US 7612044
Melanoma antigens and their use in diagnostic and therapeutic methods
granted -
US 7611693
Mechanism-based targeted pancreatic beta cell imaging and therapy
granted -
US 7612091
Caspase inhibitors and uses thereof
granted -
US 7611532
Coated implantable medical device
granted -
US 7608693
High affinity human antibodies to human IL-4 receptor
granted -
US 7608253
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
granted -
US 7608449
Methods and compositions related to high-titer pseudotyped retroviruses
granted -
US 7608714
Production of dolasetron
granted -
US 7608632
Sulfonamide inhibitors of aspartyl protease
granted -
US 7608257
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.